Certain Balance Sheet Items - Accounts Payable and Accrued Expenses (Details) - USD ($) |
3 Months Ended | ||||
|---|---|---|---|---|---|
Mar. 31, 2023 |
Feb. 28, 2023 |
Dec. 31, 2022 |
Jul. 31, 2022 |
Mar. 09, 2021 |
|
| Accounts Payable and Accrued Expenses [Line Items] | |||||
| Trade accounts payable | $ 11,194,396 | $ 19,862,487 | |||
| Accrued compensation | 7,607,673 | 12,574,921 | |||
| Accrued litigation settlement | 0 | 44,000,000 | |||
| Other accrued expenses | 5,950,102 | 3,249,477 | |||
| Total | $ 24,752,171 | $ 79,686,885 | |||
| Common stock, shares, issued (in shares) | 262,739,126 | ||||
| McDermid v. Inovio Pharmaceuticals, Inc. and J. Joseph Kim | |||||
| Accounts Payable and Accrued Expenses [Line Items] | |||||
| Estimate of cash settlement | $ 30,000,000 | $ 30,000,000 | |||
| Estimate of shares settlement | $ 14,000,000 | $ 14,000,000 | |||
| Amount paid to other party | $ 252,000 | ||||
| Common stock, shares, issued (in shares) | 9,121,000 |
| X | ||||||||||
- Definition Accounts Payable and Accrued Expenses No definition available.
|
| X | ||||||||||
- Definition Loss Contingency, Estimate of Possible Loss, Value of Shares No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount awarded to other party in judgment or settlement of litigation. No definition available.
|
| X | ||||||||||
- Definition Reflects the estimated amount of loss from the specified contingency as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|